Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial.
Saved in:
| Title: | Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial. |
|---|---|
| Authors: | Lu, Jing1 (AUTHOR), Qiu, Huiying1 (AUTHOR), Wang, Ying1 (AUTHOR), Zhou, Xin2 (AUTHOR), Dai, Haiping1 (AUTHOR), Lu, Xuzhang3 (AUTHOR), Yang, Xiaofei1 (AUTHOR), Gu, Bin1,4 (AUTHOR), Hong, Ming5 (AUTHOR), Miao, Miao1 (AUTHOR), Lu, Ruinan5 (AUTHOR), Wang, Jun4 (AUTHOR), Wu, Qian1 (AUTHOR), Xue, Mengxing1 (AUTHOR), Wang, Yun1 (AUTHOR), Deng, Ailing1 (AUTHOR), Shen, Yaoyao1 (AUTHOR), Liu, Yin1 (AUTHOR), Dou, Xueqing1 (AUTHOR), Lei, Yutian5 (AUTHOR) |
| Source: | Journal of Hematology & Oncology. 9/2/2024, Vol. 17 Issue 1, p1-5. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
